Sign in
Join
Home
About Us
Privacy Policy
Disclaimer
Advertise On Market Exclusive
Sitemap
Submit a Scoop!
Contact Us
Stock Market News
Stocks
Analyst Ratings
Insider Trading
SEC Filings
Earnings
Cannabis Stocks News
Biotech Stocks
Small Caps
Blockchain & Cryptocurrency
Become a Contributor!
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
My Account
orders
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Market Exclusive
Home
About Us
Privacy Policy
Disclaimer
Advertise On Market Exclusive
Sitemap
Submit a Scoop!
Contact Us
Stock Market News
Stocks
Analyst Ratings
Insider Trading
SEC Filings
Earnings
Cannabis Stocks News
Biotech Stocks
Small Caps
Blockchain & Cryptocurrency
Become a Contributor!
Home
Tags
BioMarin
Tag: BioMarin
Here’s Our Take On The Latest BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Submission
ME Contributor
-
July 4, 2017
0
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Scores Big, But Have The Children?
ME Contributor
-
April 28, 2017
0
A Look At The Science Behind BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)’s Next...
ME Contributor
-
October 20, 2016
0
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)’s Setback Isn’t Really A Setback
ME Contributor
-
September 7, 2016
0
A Look At The Upcoming BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) BLA
ME Contributor
-
August 5, 2016
0
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is Preparing to Release PEG-PAL Topline
ME Contributor
-
March 14, 2016
0
The Week’s Biggest Movers: Aduro BioTech Inc (NASDAQ:ADRO) and Sarepta Therapeutics...
ME Contributor
-
March 11, 2016
0
BioMarin, Sarepta’s Loss Could Be PTC’s Gain
Roger Hannington
-
January 18, 2016
0
Could the FDA Approve Both BioMarin and Sarepta’s DMD Candidates?
Roger Hannington
-
December 17, 2015
0
Two Stocks to Watch This Month in Biotech
ME Contributor
-
December 3, 2015
0
/* */
// AST – IMS - [MarketExclusive_ROS]